Real-time enrollment status for this myelofibrosis clinical trial
Current Status
Recruiting
Checked: September 7, 2026 at 5:38 AM UTC
| NCT Number | NCT07623161 |
| Recruiting Status | Recruiting |
| Condition | Myelofibrosis |
| Phase | PHASE3 |
| Target Enrollment | 324 participants |
| Active Locations | 30 sites in the US |
| Sponsor | Takeda |
| Last Updated on CT.gov | August 24, 2026 (2 weeks ago) |
As of September 7, 2026: Clinical trial NCT07623161 is currently recruiting participants. This phase3 study for myelofibrosis is actively seeking new participants at 30 locations across the United States. The study is sponsored by Takeda. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07623161 is actively recruiting participants as of September 7, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 30 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07623161 was last updated 2 weeks ago (August 24, 2026). HelloStudys verifies this status automatically.